An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...

A cervical cancer screening - which used to be known as a 'smear test' - is available for women and anyone with a cervix ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

The self-test device that Mayo Clinic will use is the Evalyn Brush. The collection brush is housed inside a plastic tube, ...

The HPV vaccine offers protection against the most common high-risk HPV strains (16 and 18) as well as others that can cause ...

Human papillomavirus (HPV) remains one of the most prevalent viral infections globally, affecting millions across ...

According to NHS, most cases of cervical cancer stem from certain types of (HPV) human papillomavirus, which know causes 99.8 per cent of cases of the disease. It is one of the most preventable forms ...

The Alabama Department of Public Health reports that there are 14,000 new HPV cases annually and 4,000 women die from the disease each year.

A new initiative, led by the Indian Medical Association (IMA) and the Federation of Obstetric and Gynaecological Societies of ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.